$RUN

Jurich Lynn Michelle sold $498K of RUN

Jurich Lynn Michelle sold 50,000 shares of Sunrun Inc. (RUN) at $9.96 ($0.50M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jurich Lynn Michelle
Published Aug 4, 2026, 2:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 2:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RUN
Neutral
high confidence
Mentioned
$RUN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RUNNeutralLow
01

Why it matters

The disclosed fact is the sale itself and that it was executed under a pre-arranged 10b5-1 plan; it does not provide new company performance, guidance, or regulatory developments.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure and modest dollar value relative to a public company typically limit actionable signal.

03

What to watch

The filing does not indicate why the sale occurred, and 10b5-1 plans are designed to reduce timing-based inference.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-04, transaction dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Sunrun Inc. (RUN) by a director, including trade size, price, and post-transaction holdings.

Company-level read

Ticker impact

$RUNNeutralHigh confidence
Context

Sunrun director Jurich Lynn Michelle sold 50,000 shares in an open-market transaction on 2026-08-03 under a 10b5-1 plan, worth about $498K.

Expected impact

Low likelihood of a sustained price move from this filing alone; any reaction would be sentiment-driven and likely muted.

Evidence & confidence

Form 4 insider sales on 10b5-1 plans are typically expected and not, by themselves, a new operational or financial catalyst for the issuer.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None.

None.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with management’s view of valuation or liquidity needs, which some traders may interpret as mildly bearish.

Key entities

  • Sunrun Inc.

    Company whose director insider sale is disclosed on Form 4.

  • Jurich Lynn Michelle

    Director who sold 50,000 shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$RUNHigh

Goldman Sachs Cut Its Sunrun Target. It Still Sees [44%] Upside

Goldman Sachs and Citi reduced their price targets for Sunrun (RUN) to $11 and $14, respectively, while maintaining Buy ratings. Analysts anticipate a decline in Sunrun's EPS from $1.71 in 2025 to $1.00 by 2027. Sunrun's stock closed at $7.61 on Oct. 7, a 52-week low. The cuts reflect lower expectations for near-term growth and cash generation.

$RUNMed

Why is Sunrun stock sliding today?

Sunrun (RUN) stock fell 2.0% to $7.46 in pre-market trading, continuing a downtrend after price target cuts from Goldman Sachs and Citi, citing lower near-term growth expectations. The stock hit a 52-week low of $7.42, down 62% over the past year. Analysts maintained Buy ratings but reduced targets to $11 and $14, respectively. A large options trade suggests hedging against further downside. The broader market decline and policy uncertainty also weighed on the stock.